Your browser doesn't support javascript.
loading
Analysis on the inhalant use and effects of pharmaceutical care intervention by clinical pharmacists in elderly patients with chronic obstructive pulmonary disease / 中华老年医学杂志
Chinese Journal of Geriatrics ; (12): 264-268, 2020.
Article in Chinese | WPRIM | ID: wpr-869367
ABSTRACT

Objective:

To investigate the effect of pharmaceutical care intervention by clinical pharmacists on inhalant use in elderly patients with chronic obstructive pulmonary disease(COPD).

Methods:

A total of 140 elderly patients with COPD were randomly divided into the control group( n=70, receiving conventional medicine education)and the study group(n=70, receiving the whole pharmaceutical care intervention as add-on to the treatment for control group for 6 months). The knowledge of inhalant medication, inhalant operation score, incorrect operation rate, disease symptom score and pulmonary function were compared between the two groups.

Results:

Compared with pretreatment, the scores of inhalant knowledge were increased significantly in both groups after treatment.While, the scores in the pharmacology, usage, precautions, and adverse reactions as well as total scores were higher in the study group than in the control group( t=5.905, 7.064, 5.356, 5.211 and 19.600, all P<0.05). The inhalant operation scores were significantly increased with time in both groups( F time=64.259, P<0.05). The increment of inhalant operation score was higher in the study group than in the control group(F time×group=5.237, P<0.05). The overall score of inhalant operation was higher in the study group than in the control group( F group=7.218, P<0.05). The incorrect operation rate was lower in the study group than in the control group(5.7% or 4/70 vs.18.6% or 13/70, χ2=5.423, P=0.020). The scores of cough, expectoration and asthma were lower in study group than in the control group( t=11.602, 9.282 and 11.225, respectively, P<0.05). The percentage of the first second force expiratory volume to the estimated value(FEV1%)and FEV 1/forced vital capacity(FVC) were higher in the study group than in the control group( t=4.049 and 3.148, all P<0.05).

Conclusions:

Pharmaceutical care intervention improves patients' awareness of COPD, increases the accuracy and compliance of inhalant use, thus alleviates the clinical symptoms and improves lung function.
Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Geriatrics Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Geriatrics Year: 2020 Type: Article